<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(2)</volume><submitter>Madlmayr A</submitter><pubmed_abstract>T-lymphocyte activation is a crucial process in the regulation of innate and adaptive immune responses. The ion channel-kinase TRPM7, &lt;u>t&lt;/u>ransient &lt;u>r&lt;/u>eceptor &lt;u>p&lt;/u>otential cation channel subfamily &lt;u>M&lt;/u>, member &lt;u>7&lt;/u>, has previously been implicated in cellular Mg&lt;sup>2+&lt;/sup> homeostasis, proliferation, and immune cell modulation. Here, we show that pharmacological and genetic silencing of TRPM7 leads to diminished activation and influences signaling pathways that guide human T&lt;sub>H&lt;/sub>17 or T&lt;sub>reg&lt;/sub> cell differentiation, following TCR-mediated stimulation. In primary human CD4 T cells and CRISPR-Cas9-engineered Jurkat T cells, inactivation or loss of TRPM7 led to distorted Mg&lt;sup>2+&lt;/sup> homeostasis and Ca&lt;sup>2+&lt;/sup> signaling, reduced NFAT translocation, de</pubmed_abstract><journal>Life science alliance</journal><pagination>e202503357</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12670122</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>TRPM7 and magnesium orchestrate human CD4 T-cell activation and differentiation.</pubmed_title><pmcid>PMC12670122</pmcid><pubmed_authors>Madlmayr A</pubmed_authors><pubmed_authors>Lewitz D</pubmed_authors><pubmed_authors>Schedlberger C</pubmed_authors><pubmed_authors>Dietrich A</pubmed_authors><pubmed_authors>Gudermann T</pubmed_authors><pubmed_authors>Weng M</pubmed_authors><pubmed_authors>Lechner M</pubmed_authors><pubmed_authors>Duggan M</pubmed_authors><pubmed_authors>Ross R</pubmed_authors><pubmed_authors>Sperandio M</pubmed_authors><pubmed_authors>Karner-Hoeger B</pubmed_authors><pubmed_authors>Hacker S</pubmed_authors><pubmed_authors>Horner K</pubmed_authors><pubmed_authors>Horgen FD</pubmed_authors><pubmed_authors>Eder J</pubmed_authors><pubmed_authors>Zierler S</pubmed_authors><pubmed_authors>Haider T</pubmed_authors><pubmed_authors>Hoelting K</pubmed_authors></additional><is_claimable>false</is_claimable><name>TRPM7 and magnesium orchestrate human CD4 T-cell activation and differentiation.</name><description>T-lymphocyte activation is a crucial process in the regulation of innate and adaptive immune responses. The ion channel-kinase TRPM7, &lt;u>t&lt;/u>ransient &lt;u>r&lt;/u>eceptor &lt;u>p&lt;/u>otential cation channel subfamily &lt;u>M&lt;/u>, member &lt;u>7&lt;/u>, has previously been implicated in cellular Mg&lt;sup>2+&lt;/sup> homeostasis, proliferation, and immune cell modulation. Here, we show that pharmacological and genetic silencing of TRPM7 leads to diminished activation and influences signaling pathways that guide human T&lt;sub>H&lt;/sub>17 or T&lt;sub>reg&lt;/sub> cell differentiation, following TCR-mediated stimulation. In primary human CD4 T cells and CRISPR-Cas9-engineered Jurkat T cells, inactivation or loss of TRPM7 led to distorted Mg&lt;sup>2+&lt;/sup> homeostasis and Ca&lt;sup>2+&lt;/sup> signaling, reduced NFAT translocation, de</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-06-05T21:04:40.628Z</modification><creation>2026-05-21T03:13:04.188Z</creation></dates><accession>S-EPMC12670122</accession><cross_references><pubmed>41326173</pubmed><doi>10.26508/lsa.202503357</doi></cross_references></HashMap>